Taken together, our data supported the notion that activation of Src kinase (evidenced by increased p-Src) likely promoted STAT6 phosphorylation to enhance its interaction with HDAC1, and subsequently the p-STAT6/HDAC1 complex acted in concert to suppress PPP3CB expression in Herceptin-resistant breast cancer cells. The gene discussed is STAT6; the disease is breast cancer.